Ribon Therapeutics
Mr. Lifschitz is a Co-Founder & General Managing Partner at Peregrine Ventures, an Israeli life sciences venture capital fund that focuses on pharmaceuticals, therapeutic devices and medical software. On behalf of Peregrine, Mr. Lifschitz serves on the boards of Memic Innovative Surgery, Ribon Therapeutics, Nectin Therapeutics, Kahr, Raziel Therapeutics, CardioValve, Cordio Medical and others. Mr. Lifschitz serves as the Chairman of the Israeli Early-Stage Investors association (IEI) & Technology Incubator Forum (ITIF).
This person is not in the org chart
This person is not in any offices
Ribon Therapeutics
Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.